Back to Journals » OncoTargets and Therapy » Volume 11

ROS-dependent Bax/Bcl2 and caspase 3 pathway-mediated apoptosis induced by zineb in human keratinocyte cells

Authors Ali D, Tripathi A, Al Ali H, Shahi Y, Mishra KK, Alarifi S, Alkahtane AA, Manohardas S

Received 24 April 2017

Accepted for publication 9 October 2017

Published 23 January 2018 Volume 2018:11 Pages 489—497


Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Ashok Kumar Pandurangan

Peer reviewer comments 4

Editor who approved publication: Prof. Dr. Geoffrey Pietersz

Daoud Ali,1 Abhilasha Tripathi,2 Hussain Al Ali,3 Yadvendra Shahi,2 Kamlesh K Mishra,2 Saud Alarifi,1 Abdullah A Alkahtane,1 Salem Manohardas1

1Department of Zoology, Science College, King Saud University, Riyadh, Saudi Arabia; 2CytoGene Research and Development, Lucknow, India; 3Centre of Excellence for Genomics, King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia

Abstract: There are a large number of agricultural workers who are exposed to pesticides through skin and inhalation. The best approach to identify altered molecular pathways during dermal exposure to pesticides is relevant to risk-associated concern about skin safety. In this study, we investigated the cytotoxic effect of zineb, a fungicide, in human keratinocyte (HaCaT) cells. HaCaT cells were treated with zineb (1–40 µg/mL) for 24 hours. Cellular and molecular mechanisms of cell toxicity were investigated through MTT and neutral red-uptake assays. Zineb reduced viability of HaCaT cells and induced apoptosis in a concentration-dependent manner. Zineb increased levels of Bax and caspase 3 and inhibited the level of Bcl2, which subsequently induced apoptosis via the Bax/Bcl2 and caspase pathway. Therefore, zineb could have induced apoptosis through the mitochondrial pathway in HaCaT cells. Our study suggests that zineb is cytotoxic to HaCaT cells via the induction of apoptosis and oxidative stress in vitro.

Keywords: zineb, HaCaT cells, apoptosis, MTT assay, DNA damage

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]